TeselaGen Press Releases

Scientist Proteins

Arzeda leverages scalable Synthetic Biology resources to drive computational protein design platform

Arzeda, the Protein Design CompanyTM, Twist Bioscience Corporation, TeselaGen Biotechnology Inc. and Labcyte Inc. have partnered to build a state-of-the-art DNA assembly platform to significantly reduce the time and cost required to build genes encoding Arzeda’s designed proteins. (…)
“The platform we are building with Arzeda significantly accelerates workflows by optimizing information flow. It has been an exciting collaboration that continues to expand as we move downstream into the TEST and EVOLVE modules for analytic data acquisition and analysis,” said Michael Fero, Ph.D., CEO of TeselaGen.

Read More »

Dow AgroSciences and TeselaGen Advance Biodesign Technologies for Agriculture

Using the power of nature in conjunction with advanced technology and informatics to produce and develop solutions for farmers is essential to advance agriculture. Today, TeselaGen Biotechnology Inc., and Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), announced they have entered into a collaboration to produce a state-of-the-art biological design automation platform that can speed discovery work.

Read More »
Design editor

TeselaGen receives NSF SBIR Award

TeselaGen has received a $750,000 grant from the National Science Foundation to expand its computer aided design platform for building and modifying DNA with synthetic biology techniques. The Small Business Innovation Research Phase II grant will be used to further commercialize the “j5” technology under exclusive license from the Lawrence Berkeley National Laboratory.

Read More »


We're committed to your privacy. TeselaGen uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time.